Genome‐wide association studies in the Japanese population identified genetic loci and target gene associated with epidermal turnover

The epidermis is an essential organ for life by retaining water and as a protective barrier. The epidermis is maintained through metabolism, in which basal cells produced from epidermal stem cells differentiate into spinous cells, granular cells and corneocytes, and are finally shed from the epidermal surface. This is epidermal turnover, and with aging, there is a decline in epidermis function. Other factors that may affect epidermal turnover include ultraviolet damage and genetic factors. These genetic factors are of particular interest as little is known. Although recent skin-focused genome-wide association studies (GWAS) have been conducted, the genetic regions associated with epidermal turnover are almost uninvestigated. Therefore, we conducted a GWAS on epidermal turnover in the Japanese population, using the corneocyte area, which correlates to the rate of epidermal turnover, as an indicator. As a result, rs2278431 (p = 1.29 × 10-7 ) in 19q13.2 was associated with corneocyte size. Furthermore, eQTL analysis suggested that rs2278431 was related to the SPINT2 gene. In addition, SPINT2 knockdown studies using epidermal keratinocytes revealed that SPINT2 is involved in keratinocyte proliferation and in corneocyte size regulation in reconstructed epidermis. These results suggest that rs2278431 is involved in the expression of SPINT2 and affects epidermal turnover.

[1]  Takaaki Yamada,et al.  Identification of mitochondrial genetic variants associated with human corneocyte size in Japanese women , 2022, Experimental dermatology.

[2]  Takaaki Yamada,et al.  Genome‐wide association studies in Japanese women identified genetic loci associated with wrinkles and sagging , 2022, Experimental dermatology.

[3]  M. Arima,et al.  Increase in inhibin beta A/Activin-A expression in the human epidermis and the suppression of epidermal stem/progenitor cell proliferation with aging. , 2022, Journal of dermatological science.

[4]  Takaaki Yamada,et al.  Search for genetic loci involved in the constitution and skin type of a Japanese women using a genome‐wide association study , 2021, Experimental dermatology.

[5]  H. Scherthan,et al.  Human skin aging is associated with increased expression of the histone variant H2A.J in the epidermis , 2021, NPJ aging and mechanisms of disease.

[6]  Li Jin,et al.  Genome-wide scan identified genetic variants associated with skin aging in a Chinese female population. , 2019, Journal of dermatological science.

[7]  M. Nagasaki,et al.  Susceptibility Loci for Tanning Ability in the Japanese Population Identified by a Genome-Wide Association Study from the Tohoku Medical Megabank Project Cohort Study. , 2019, The Journal of investigative dermatology.

[8]  Sari Ipponjima,et al.  Development of 3D imaging technique of reconstructed human epidermis with immortalized human epidermal cell line , 2018, Experimental dermatology.

[9]  C. Kao,et al.  Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin , 2018, PloS one.

[10]  Michael D. Johnson,et al.  Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells , 2018, Oncotarget.

[11]  D. Posthuma,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[12]  Alejandro Cabrera-Wrooman,et al.  DPFF‐1 transcription factor deficiency causes the aberrant activation of MPK‐1 and meiotic defects in the Caenorhabditis elegans germline , 2017, Genesis.

[13]  B. Ryu,et al.  Epigenetic Silencing of SPINT2 promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma , 2015, The Journal of investigative dermatology.

[14]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[15]  Michael D. Johnson,et al.  HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase , 2014, Oncogene.

[16]  E. Grimm,et al.  Identification of unique sensitizing targets for anti‐inflammatory CDDO‐Me in metastatic melanoma by a large‐scale synthetic lethal RNAi screening , 2013, Pigment cell & melanoma research.

[17]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[18]  Christopher Bergum,et al.  Loss of the matriptase inhibitor HAI‐2 during prostate cancer progression , 2010, The Prostate.

[19]  F. Furukawa,et al.  Effects of adenosine 5′-monophosphate on epidermal turnover , 2008, Archives of Dermatological Research.

[20]  H. Itoh,et al.  Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma. , 2004, The Journal of urology.

[21]  O. Yokosuka,et al.  Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. , 2003, Cancer research.

[22]  G. Grove,et al.  Age-associated changes in human epidermal cell renewal. , 1983, Journal of gerontology.

[23]  H. Akamatsu,et al.  Establishment of Three Types of Immortalized Human Skin Stem Cell Lines Derived from the Single Donor. , 2021, Biological & pharmaceutical bulletin.

[24]  Stacey S. Cherny,et al.  Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets , 2011, Human Genetics.

[25]  Tanya M. Teslovich,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[26]  A. Hongo,et al.  Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.